Bicara Therapeutics Inc. (BCAX)
NASDAQ:BCAX
Want to see BCAX full AI Analyst Report?
BCAX Analyst Ratings
Strong Buy
9 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BCAX Stock 12 Month Forecast
Average Price Target
$30.55
▲(27.22% Upside)
| Highest Price Target$46.00 | Average Price Target$30.55 | Lowest Price Target$16.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
JonesTrading
$30
Buy
24.95%
Upside
Reiterated
05/22/26
Bank of America Securities
―
Buy
―
Reiterated
05/22/26
Stifel Nicolaus
$46
Buy
91.59%
Upside
Reiterated
05/12/26
Morgan Stanley
$37→$22.92
Buy
-4.54%
Downside
Assigned
05/12/26
TD Cowen
―
Buy
―
Reiterated
05/11/26
BTIG
$28
Buy
16.62%
Upside
Reiterated
05/11/26
Goldman Sachs
$16→$18
Hold
-25.03%
Downside
Assigned
05/11/26
Guggenheim
$42
Buy
74.93%
Upside
Initiated
05/10/26
Wells Fargo
$20→$16
Hold
-33.36%
Downside
Assigned
04/01/26
H.C. Wainwright
$40→$42
Buy
74.93%
Upside
Reiterated
03/31/26
Citizens JMP
$31
Buy
29.11%
Upside
Initiated
01/29/26
Mizuho Securities
$18
Hold
-25.03%
Downside
Initiated
12/18/25
Piper Sandler
$36
Buy
49.94%
Upside
Reiterated
12/08/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
JonesTrading
$30
Buy
24.95%
Upside
Reiterated
05/22/26
Bank of America Securities
―
Buy
―
Reiterated
05/22/26
Stifel Nicolaus
$46
Buy
91.59%
Upside
Reiterated
05/12/26
Morgan Stanley
$37→$22.92
Buy
-4.54%
Downside
Assigned
05/12/26
TD Cowen
―
Buy
―
Reiterated
05/11/26
BTIG
$28
Buy
16.62%
Upside
Reiterated
05/11/26
Goldman Sachs
$16→$18
Hold
-25.03%
Downside
Assigned
05/11/26
Guggenheim
$42
Buy
74.93%
Upside
Initiated
05/10/26
Wells Fargo
$20→$16
Hold
-33.36%
Downside
Assigned
04/01/26
H.C. Wainwright
$40→$42
Buy
74.93%
Upside
Reiterated
03/31/26
Citizens JMP
$31
Buy
29.11%
Upside
Initiated
01/29/26
Mizuho Securities
$18
Hold
-25.03%
Downside
Initiated
12/18/25
Piper Sandler
$36
Buy
49.94%
Upside
Reiterated
12/08/25
Best Analysts Covering Bicara Therapeutics Inc.
3 Months
Success Rate
8/12 ratings generated profit
Average Return
+12.02%
Copying Robert Burns's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +12.02% per trade.
1 Year
Success Rate
11/12 ratings generated profit
Average Return
+45.13%
Copying Robert Burns's trades and holding each position for 1 Year would result in 91.67% of your transactions generating a profit, with an average return of +45.13% per trade.
2 Years
Success Rate
11/12 ratings generated profit
Average Return
+49.07%
Copying Robert Burns's trades and holding each position for 2 Years would result in 91.67% of your transactions generating a profit, with an average return of +49.07% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BCAX Analyst Recommendation Trends
Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
18
18
15
8
7
Buy
4
2
2
3
10
Hold
2
2
2
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
24
22
19
14
20
Each month's total comprises the sum of three months' worth of ratings.
BCAX Financial Forecast
BCAX Stock Forecast FAQ
What is BCAX’s average 12-month price target, according to analysts?
Based on analyst ratings, Bicara Therapeutics Inc.’s 12-month average price target is 30.55.
What is BCAX’s upside potential, based on the analysts’ average price target?
Bicara Therapeutics Inc. has 27.22% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BCAX a Buy, Sell or Hold?
Bicara Therapeutics Inc. has a consensus rating of Strong Buy which is based on 9 buy ratings, 2 hold ratings and 0 sell ratings.
What is Bicara Therapeutics Inc.’s price target?
The average price target for Bicara Therapeutics Inc. is 30.55. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $46.00 ,the lowest forecast is $16.00. The average price target represents 27.22% Increase from the current price of $24.01.
The highest analyst price target is $46.00 ,the lowest forecast is $16.00. The average price target represents 27.22% Increase from the current price of $24.01.
What do analysts say about Bicara Therapeutics Inc.?
Bicara Therapeutics Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of BCAX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.